HNB
BBIO icon

Huntington National Bank’s BridgeBio Pharma BBIO Stock Holding History

Huntington National Bank’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.2K Buy
969
+58
+6% +$4.06K ﹤0.01% 1297
2026
Q1 		$67.7K Buy
911
+175
+24% +$12.7K ﹤0.01% 1218
2025
Q4 		$56.3K Sell
736
-7
-0.9% -$459 ﹤0.01% 1200
2025
Q3 		$38.6K Buy
743
+392
+112% +$19.1K ﹤0.01% 1362
2025
Q2 		$15.2K Buy
351
+250
+248% +$9.09K ﹤0.01% 1657
2025
Q1 		$3.49K Buy
101
+100
+10,000% +$3.37K ﹤0.01% 2091
2024
Q4 		$27 Buy
+1
New +$26 ﹤0.01% 3340

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Huntington National Bank's BBIO Position: Q2 2026 in Review

Huntington National Bank increased its BridgeBio Pharma (BBIO) stake by 6.4% in Q2 2026, buying an estimated $4.06K and bringing the position to 969 shares worth $72.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

Huntington National Bank first reported a position in BBIO in Q4 2024 and has held it in 7 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Huntington National Bank held 969 shares of BridgeBio Pharma worth $72.2K as of Q2 2026.
  • Huntington National Bank bought 58 BridgeBio Pharma shares in Q2 2026, an estimated $4.06K.
  • BridgeBio Pharma made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1297 holding.
  • Huntington National Bank first reported a position in BridgeBio Pharma in Q4 2024 and has held it in 7 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.